“Mind the Gap” in Deal-Making

Meghan Fleming
bottom-6

Show me the data

When it comes to deal valuation for early technologies, how can both sides find common ground? That’s the question tackled by biotech CEOs and venture capitalists in this session moderated by Michael Ward, Head of Thought Leadership, Life Sciences and Healthcare, at Clarivate.

The panelists included biotech CEOs Werner Lanthale of Evotec and Caroline Loew of Glympse Bio, while the venture capital side was represented by Chris Garabedian, Chairman & CEO of Xontogeny and Asish Xavier, Vice President, Venture Investments of Johnson & Johnson Innovation.

For investors, the biggest challenge comes down to managing risk. Garabedian summed it up succinctly by commenting that

“99 percent of things that look good in a mouse, fail to get FDA approval.”

Chris Garabedian of Xontogeny

How can early-stage labs and biotechs convince investors of the value of their program? It all comes down to data.

The panelists were unanimous in their advice, no deals should be made based on aspirational conversations. Biotechs and research labs should concentrate on conducting experiments and translational research that signal therapeutic relevance. Strong data is the best way to derisk an investment and convince partners of the value of the technology.

Other advice included keeping an open dialogue with partners and looking for ways to co-create value together. As Loew commented, “The companies that are successful in dealmaking are the ones that know how to go through that dialogue. They know how to build a strategy both for their company and the company that they’re collaborating with.”

Source: BIO Digital 2021

shape-2

Community illustration

Testimonials
Testimonials

Why our customers love Inova

Advancing Innovation in Dermatology

Inova’s technology allowed the dermatology innovation community to connect in a robust way during our Annual Dermatology Summit held virtually. One-on-One Partnering™ enabled valuable networking discussions, even with attendees remotely situated.

13977
Jamie BreslinDirector, Operations & Partnerships
HealthTech For Care

During the HealthTech Innovation Days in 2020, HealthTech For Care used the Inova platform to establish more than 1,000 private meetings in 3 days with participants attending from all over the world!

13966
Maryvonne HiancePresident
Lyonbiopole

Inova’s platform has been instrumental in the success of our partnering events and has helped foster collaborations between our regional startups and international strategic partners.

13971
Florence Agostino EtchettoGeneral Manager

Talk to one of our experts

Schedule a live and personalized demo with our experts
We’re always happy to help find the solution for your needs.
Schedule a demo today